Ainos Inc (NAS:AIMD)
$ 0.845 0.0206 (2.5%) Market Cap: 5.50 Mil Enterprise Value: 10.01 Mil PE Ratio: 0 PB Ratio: 0.23 GF Score: 42/100

Ainos Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript

Feb 02, 2023 / 06:30PM GMT
Release Date Price: $3.95
Jack Lu
Ainos, Inc. - Director of Corporate Development

Good afternoon. My name is Jack Lu, Director of Corporate Development at Ainos. Thank you for watching this presentation. Ainos is a diversified med tech company. We are building three key technologies to integrate precision medicine and telehealth.

We have innovative POCTs that are portable, telehealth-friendly, and deliver a fast result. All tests are non-invasive.

VELDONA stands for very low-dose oral interferon alpha. Interferon is part of humans' natural immune system. Conventional interferon treatments are high-dose injectable forms and could cause serious side effects. We believe VELDONA is a safe and convenient way to help you fight against diseases by strengthening your immune system, and Ainos has been the pioneer of low-dose oral interferon for many years.

SRNA stands for synthetic RNA. We are building a technology platform to develop next-generation precision treatments and rapid tests.

When all three technologies work together, we believe it is a cohesive telehealth-enabled medtech solution,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot